slides · global inventory
All filtered slides
Global slide inventory for the active corpus filters, with each row opening the slide detail view.
Corpus coverage
319,975 slides
319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.
- Total slides
- 319,975
- Described
- 319,974
- Pending
- 1
100%ready for canon
Slide type composition
dynamicclickable
Slide type
Showing 319,974 described slides — 100.0% of 319,975 rendered pages
+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs
Tile area is proportional to slide count. Click a category to open its subtype map.
all document kinds · all orientations
Slide collection
225,721-225,780 of 319,975
04
Uses an analogy to establish market positioning.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations 1 hit
05
Freightos | Investor Presentation Deck | 35 slidesFreightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations 1 hit
06
Uses a value-chain style diagram to show the complexity of the current market.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
The slide uses a map-based layout to connect specific logistics pain points to the global supply chain.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
08
Uses a funnel-like diagram to isolate the 'Opportunity Spotlight' segment.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Beat · Market Size1 hit
09
The slide uses a chronological progression framework to illustrate the evolution of business models.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Beat · Market Size1 hit
10
Uses an analogy to travel booking platforms (Amadeus/Sabre and Booking.com/Expedia) to explain the business model.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Beat · Solution1 hit
11
The slide uses a value-chain style flow to show the integration of different market participants.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Beat · Solution1 hit
12
Freightos | Investor Presentation Deck | 35 slidesFreightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations 1 hit
13
The chart uses a trend line to emphasize the growth trajectory.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Beat · Traction1 hit
14
The slide uses callouts to annotate specific UI elements of the WebCargo booking interface.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Beat · Traction1 hit
15
The slide uses callouts to annotate specific UI elements of the platform.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Beat · Traction1 hit
16
The slide uses a screenshot of the software interface with callouts pointing to specific features like trade lane data, market events, and transit time reports.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Beat · Traction1 hit
17
Freightos | Investor Presentation Deck | 35 slidesFreightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Beat · Traction1 hit
18
The chart tracks the percentage of bookings placed by forwarder cohorts relative to their initial first-quarter bookings.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Beat · Traction1 hit
19
Freightos | Investor Presentation Deck | 35 slidesFreightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Beat · Financials1 hit
20
The slide uses a flywheel concept to frame the growth metrics.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Beat · Financials1 hit
21
The slide illustrates the dual revenue stream model of the company.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Beat · Financials1 hit
22
The slide uses a combination of a grouped bar chart for internal financial performance and a single-series bar chart for competitive benchmarking.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Beat · Financials1 hit
23
The slide uses two bar charts to demonstrate improving financial health.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Beat · Financials1 hit
24
The slide provides ranges for transaction volume, GBV, revenue, and adjusted EBITDA, along with year-over-year growth percentages.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Beat · Financials1 hit
25
Freightos | Investor Presentation Deck | 35 slidesFreightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Beat · Financials1 hit
26
This is a closing slide for an investor presentation.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
27
Freightos | Investor Presentation Deck | 35 slidesFreightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
28
Freightos | Investor Presentation Deck | 35 slidesFreightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations 1 hit
29
The table includes a significant one-time share listing expense in Q1 2023.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations 1 hit
30
The table shows adjustments for non-cash and non-recurring items to arrive at Adjusted EBITDA.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations 1 hit
31
The table reconciles IFRS gross profit to non-IFRS gross profit by adding back share-based compensation and depreciation & amortization.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations 1 hit
32
Values are in $K. The table shows a trend of increasing revenue alongside increasing operating losses.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations 1 hit
33
The table adjusts IFRS gross profit by adding back share-based compensation and depreciation & amortization to arrive at Non-IFRS gross profit.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations 1 hit
34
The table details non-GAAP adjustments including share-based compensation, D&A, and various one-time costs.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations 1 hit
35
Freightos | Investor Presentation Deck | 35 slidesFreightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations 1 hit
01
Fusion Pharmaceuticals | Investor Presentation Deck | 26 slidesFusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
02
Fusion Pharmaceuticals | Investor Presentation Deck | 26 slidesFusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
03
The slide uses a four-column layout to summarize the company's value proposition.Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · Problem1 hit
04
Fusion Pharmaceuticals | Investor Presentation Deck | 26 slidesFusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · Problem1 hit
05
The slide uses a before/after PET scan visual to demonstrate clinical efficacy.Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · Problem1 hit
06
The slide uses a process diagram to show the evolution of the FPI-2265 program.Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · Solution1 hit
07
The slide uses a process flow diagram to illustrate the transition from Phase 2 (n=60) to Phase 3 (n=550).Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · Solution1 hit
08
Uses a combination of clinical trial data (VISION) and market projections to justify the TAM for FPI-2265.Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · Solution1 hit
09
Fusion Pharmaceuticals | Investor Presentation Deck | 26 slidesFusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · Solution1 hit
10
Fusion Pharmaceuticals | Investor Presentation Deck | 26 slidesFusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
11
The slide uses a comparative structure to highlight the superiority of alpha particles in DNA damage and clinical logistics.Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
12
The slide highlights a partnership-based supply chain and a proprietary onsite generator technology to mitigate risks associated with traditional cyclotron production.Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
13
Highlights internal manufacturing readiness and scale.Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
14
Fusion Pharmaceuticals | Investor Presentation Deck | 26 slidesFusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
15
The slide uses a standard pharmaceutical pipeline visualization format.Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
16
The slide compares clinical trial data from two different studies (Morris et al. 2017 and Hofman et al. 2018) to illustrate the efficacy of different PSMA-targeting agents.Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · Competition1 hit
17
Includes a visual comparison between a 'cold' antibody and the 'hot' FPI-1434 conjugate.Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
18
Includes medical imaging (SPECT/CT) comparing baseline vs. cold antibody intervention.Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
19
Includes before/after PET-CT scan imagery.Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
20
Fusion Pharmaceuticals | Investor Presentation Deck | 26 slidesFusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
21
The chart shows a clear dose-dependent reduction in tumor volume compared to vehicle and cold antibody controls.Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
22
The slide uses a 'before-after' logic to explain the transition from 177Lu to 225Ac.Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
23
Includes headshots, titles, key experience bullets, and a grid of company logos representing past experience.Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · Team1 hit
24
Includes a footnote explaining the pro forma cash calculation.Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
25
Fusion Pharmaceuticals | Investor Presentation Deck | 26 slidesFusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
26
Fusion Pharmaceuticals | Investor Presentation Deck | 26 slidesFusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
01
Goldman Sachs | Results Presentation Deck | 25 slidesGoldman Sachs | Results Presentation Deck | 25 slides · Goldman Sachs
Conference presentation Investor relations 1 hit
02
The slide uses a visual connection between the firm's values (left) and its strategic pillars (right).Goldman Sachs | Results Presentation Deck | 25 slides · Goldman Sachs
Conference presentation Investor relations Beat · Attention1 hit